$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

$cpsh Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000143774922011434 Filed on May 09, 2022

Income Statement

Concept	2022 Q2	2021 Q1
Revenue	$6.653M	$4.866M
YoY Change	13.49%	-25.26%
Cost Of Revenue	$4.689M	$3.922M
YoY Change	3.96%	-20.94%
Gross Profit	$1.963M	$944.1K
YoY Change	45.27%	-39.09%
Gross Profit Margin	29.51%	19.4%
Selling, General & Admin	$1.416M	$908.5K
YoY Change	28.92%	-2.31%
% of Gross Profit	72.14%	96.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$105.1K	$148.7K
YoY Change	-21.79%	14.42%
% of Gross Profit	5.35%	15.75%
Operating Expenses	$1.416M	$908.5K
YoY Change	28.93%	-2.31%
Operating Profit	$547.1K	$35.67K
YoY Change	116.27%	-94.25%
Interest Expense	-$2.270K	$0.00
YoY Change	-83.51%	-100.0%
% of Operating Profit	-0.41%	0.0%
Other Income/Expense, Net	$360.00	-$4.310K
YoY Change		-78.45%
Pretax Income	$545.2K	$31.36K
YoY Change	127.92%	-94.77%
Income Tax	$125.8K	$456.00
% Of Pretax Income	23.07%	1.45%
Net Earnings	$419.4K	$30.90K
YoY Change	75.35%	-94.85%
Net Earnings / Revenue	6.3%	0.64%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	$28.62K	$0.00
COMMON SHARES
Basic Shares Outstanding	14.43M	13.58M
Diluted Shares Outstanding		14.26M

Balance Sheet

Concept	2022 Q2	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.700M	$170.0K
YoY Change	55.84%	41.67%
Cash & Equivalents	$4.700M	$167.9K
Short-Term Investments
Other Short-Term Assets	$335.0K	$290.0K
YoY Change	22.46%	26.09%
Inventory	$4.706M	$3.630M
Prepaid Expenses
Receivables	$4.903M	$3.780M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$14.64M	$7.870M
YoY Change	25.03%	-20.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.322M	$1.850M
YoY Change	-26.97%	18.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.699M	$120.0K
YoY Change	2206.57%	-20.0%
Total Long-Term Assets	$4.579M	$1.970M
YoY Change	137.53%	15.2%
TOTAL ASSETS
Total Short-Term Assets	$14.64M	$7.870M
Total Long-Term Assets	$4.579M	$1.970M
Total Assets	$19.22M	$9.840M
YoY Change	40.93%	-15.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.621M	$1.500M
YoY Change	6.5%	-42.75%
Accrued Expenses	$648.2K	$680.0K
YoY Change	-43.58%	-18.07%
Deferred Revenue	$1.753M
YoY Change
Short-Term Debt	$0.00	$190.0K
YoY Change		-87.97%
Long-Term Debt Due	$51.62K	$60.00K
YoY Change	-13.16%	20.0%
Total Short-Term Liabilities	$4.226M	$2.750M
YoY Change	34.97%	-49.54%
LONG-TERM LIABILITIES
Long-Term Debt	$87.99K	$140.0K
YoY Change	-29.37%	-12.5%
Other Long-Term Liabilities	$401.0K	$520.0K
YoY Change	-17.66%
Total Long-Term Liabilities	$489.0K	$660.0K
YoY Change	-20.04%	312.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.226M	$2.750M
Total Long-Term Liabilities	$489.0K	$660.0K
Total Liabilities	$4.674M	$3.410M
YoY Change	24.89%	-39.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.38M
YoY Change
Common Stock	$144.4K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$20.85K
YoY Change
Treasury Stock Shares	$4.318K
Shareholders Equity	$13.85M	$6.426M
YoY Change
Total Liabilities & Shareholders Equity	$19.02M	$9.840M
YoY Change	39.43%	-15.25%

Cashflow Statement

Concept	2022 Q2	2021 Q1
OPERATING ACTIVITIES
Net Income	$419.4K	$30.90K
YoY Change	75.35%	-94.85%
Depreciation, Depletion And Amortization	$105.1K	$148.7K
YoY Change	-21.79%	14.42%
Cash From Operating Activities	-$379.3K	-$183.3K
YoY Change	-859.15%	-20.33%
INVESTING ACTIVITIES
Capital Expenditures	-$94.68K	$42.49K
YoY Change	-23.35%	-138.63%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$10.00K
YoY Change	-100.0%	0.0%
Cash From Investing Activities	-$94.68K	-$30.49K
YoY Change	-29.09%	-69.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	123.3K	$186.5K
YoY Change	-95.78%	-41.73%
NET CHANGE
Cash From Operating Activities	-379.3K	-$183.3K
Cash From Investing Activities	-94.68K	-$30.49K
Cash From Financing Activities	123.3K	$186.5K
Net Change In Cash	-350.6K	-$27.29K
YoY Change	-112.34%	172.85%
FREE CASH FLOW
Cash From Operating Activities	-$379.3K	-$183.3K
Capital Expenditures	-$94.68K	$42.49K
Free Cash Flow	-$284.6K	-$225.7K
YoY Change	-264.05%	88.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14350451
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14429009
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14423486
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14350786
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14422311
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	1175
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	335
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4310	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	125748	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32497	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	793924	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-78319	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	594037	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-272543	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-125292	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	193395	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	186455	USD
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	328400	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	283907	USD
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4699694	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5050312	USD
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4902518	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4870021	USD
CY2022Q2	us-gaap	Inventory Net InventoryNet	4705526	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	3911602	USD
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	334963	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	225873	USD
CY2022Q2	us-gaap	Assets Current AssetsCurrent	14642701	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	14057808	USD
CY2022Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10526008	USD
CY2021Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10489729	USD
CY2022Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	738205	USD
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	673305	USD
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	968509	USD
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	951384	USD
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12232722	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12114418	USD
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11133276	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11028154	USD
CY2022Q2	cpsh	Construction In Progress Net ConstructionInProgressNet	223048	USD
CY2021Q4	cpsh	Construction In Progress Net ConstructionInProgressNet	246669	USD
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1322494	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1332933	USD
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	558000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	586000	USD
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2698686	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2823978	USD
CY2022Q2	us-gaap	Assets Assets	19221881	USD
CY2021Q4	us-gaap	Assets Assets	18800719	USD
CY2022Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	51620	USD
CY2021Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	55906	USD
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2251122	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2100251	USD
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	717482	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1086429	USD
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1707138	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1707138	USD
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	157000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	155000	USD
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4884362	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5104724	USD
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	87988	USD
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	98684	USD
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	401000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	431000	USD
CY2022Q2	us-gaap	Liabilities Liabilities	5373350	USD
CY2021Q4	us-gaap	Liabilities Liabilities	5634408	USD
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	144235	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	143508	USD
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39546975	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39281810	USD
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25837056	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26256492	USD
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	5623	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2515	USD
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13848531	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13166311	USD
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19221881	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18800719	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6652714	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4865708	USD
	us-gaap	Revenues Revenues	6652714	USD
CY2021Q1	us-gaap	Revenues Revenues	4865708	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4689224	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3921568	USD
	us-gaap	Gross Profit GrossProfit	1963490	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	944140	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1416393	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	908471	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	547097	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	35669	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1913	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	545184	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31359	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	456	USD
	us-gaap	Net Income Loss NetIncomeLoss	419436	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	30903	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14389857
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13584376
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14657939
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14264890
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13166311	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	124471	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9614	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	147927	USD
	us-gaap	Net Income Loss NetIncomeLoss	419436	USD
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13848531	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6357664	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27422	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10310	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	30903	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	6426299	USD
	us-gaap	Net Income Loss NetIncomeLoss	419436	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	30903	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	105121	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	148743	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	124471	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	27422	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	12000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	863403	USD
	cpsh	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	109090	USD
CY2021Q1	cpsh	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	221769	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	150871	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-368947	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	307039	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-379267	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-183252	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	94683	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42488	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	12000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94683	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30488	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	138313	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10310	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	14981	USD
CY2021Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	17250	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	123332	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-350618	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-27285	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5050312	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	195203	USD
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4699694	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	167918	USD
	us-gaap	Interest Paid Net InterestPaidNet	2269	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	14831	USD
	us-gaap	Stock Issued1 StockIssued1	3108	USD
CY2021Q1	us-gaap	Stock Issued1 StockIssued1	1205186	USD
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	268082
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	680514
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14657939
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14264890
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q2	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	38000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Net Income Loss NetIncomeLoss	419436	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	30903	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14389857
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13584376
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.08
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	613800
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.98
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	840
CY2021Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	120196
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	971600
	us-gaap	Net Income Loss NetIncomeLoss	419436	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	30903	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14389857
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13584376
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	122000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	162000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	165000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	165000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	28000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	642000	USD
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	84000	USD
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	558000	USD
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	157000	USD
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	401000	USD
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	558000	USD
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P47M
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.066	pure
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	72700
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.37
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M1D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	837700
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.92
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y8M26D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1500000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	941000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	513700
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	622000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M14D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	124000	USD
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	27000	USD
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	44724	USD
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	2166385	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2080778	USD
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1880465	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1309572	USD
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	987076	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	805159	USD
CY2022Q2	us-gaap	Inventory Gross InventoryGross	5033926	USD
CY2021Q4	us-gaap	Inventory Gross InventoryGross	4195509	USD
CY2022Q2	us-gaap	Inventory Net InventoryNet	4705526	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	3911602	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	79917	USD
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	526128	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	905698	USD
CY2022Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	146630	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	100814	USD
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	717482	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1086429	USD
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	41050	USD
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	43837	USD
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	46757	USD
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	8090	USD
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	139734	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	2269	USD
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	125748	USD

Files In Submission

Name	View Source	Status
0001437749-22-011434-index-headers.html	Edgar Link	pending
0001437749-22-011434-index.html	Edgar Link	pending
0001437749-22-011434.txt	Edgar Link	pending
0001437749-22-011434-xbrl.zip	Edgar Link	pending
cpsh-20220402.xsd	Edgar Link	pending
cpsh-20220402_cal.xml	Edgar Link	unprocessable
cpsh-20220402_def.xml	Edgar Link	unprocessable
cpsh-20220402_lab.xml	Edgar Link	unprocessable
cpsh-20220402_pre.xml	Edgar Link	unprocessable
cpsh20220326_10q.htm	Edgar Link	pending
cpsh20220326_10q_htm.xml	Edgar Link	completed
ex_371302.htm	Edgar Link	pending
ex_371303.htm	Edgar Link	pending
ex_371304.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2022 Q2 Form 10-Q Financial Statement

#000143774922011434 Filed on May 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2022 Q2 Form 10-Q Financial Statement

#000143774922011434 Filed on May 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh